COMBINED CLINICAL EFFECT OF AMIKACIN AND CEFOXITIN IN PATIENTS WITH SEVERE INFECTIONS COMPLICATED WITH HEMATOLOGICAL DISEASES

A clinical investigation was made on the concurrent use of amikacin (AMK) and cefoxitin (CFX) against complicated infections with hematological disorders. The results obtained were summarized as follows: 1. Eleven patients were treated with AMK and CFX. Clinical responses were excellent in 2 (18%),...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Japanese journal of antibiotics 1987/03/25, Vol.40(3), pp.469-475
Hauptverfasser:	UNO, NOBUO, NOSAKA, TETSUYA, UCHIYAMA, SATOSHI, KAWAKAMI, KEIKI, HOSHINO, KENICHIROU, MORI, MIKI, HOTTA, YASUNORI, OHTA, CHIZUKO, KOBAYASHI, TOURU, KITA, KENKICHI, SHIRAKAWA, SHIGERU
Format:	Artikel
Sprache:	jpn
Schlagworte:	Adolescent Adult Aged Amikacin - administration & dosage Bacterial Infections - drug therapy Cefoxitin - administration & dosage Drug Evaluation Drug Therapy, Combination Female Humans Leukemia - complications Male Middle Aged
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A clinical investigation was made on the concurrent use of amikacin (AMK) and cefoxitin (CFX) against complicated infections with hematological disorders. The results obtained were summarized as follows: 1. Eleven patients were treated with AMK and CFX. Clinical responses were excellent in 2 (18%), good in 4 (36%), fair in 1 (9%), and poor in 4 (36%), with an efficacy rate of 64%. 2. No significant side effects requiring cessation of the treatment were observed.
ISSN:	0368-2781 2186-5477
DOI:	10.11553/antibiotics1968b.40.469